Bombay Kunststoff Pharma Supplies Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 28.90 M
as on 06-07-2024
- Revenue 109.19%
(FY 2016)
- Profit 218.92%
(FY 2016)
- Ebitda 92.76%
(FY 2016)
- Net Worth 15.13%
(FY 2016)
- Total Assets 12.74%
(FY 2016)
About Bombay Kunststoff Pharma Supplies
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.89 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Justin Martins and Raoul Verma serve as directors at the Company.
- CIN/LLPIN
U45200MH1986PTC038950
- Company No.
038950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bombay Kunststoff Pharma Supplies?
Board Members(2)
Financial Performance and Corporate Structure Insights of Bombay Kunststoff Pharma Supplies.
Bombay Kunststoff Pharma Supplies Pvt Ltd, for the financial year ended 2016, experienced significant growth in revenue, with a 109.19% increase. The company also saw a substantial improvement in profitability, with a 218.92% increase in profit. The company's net worth Soared by an impressive increase of 15.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bombay Kunststoff Pharma Supplies?
In 2017, Bombay Kunststoff Pharma Supplies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Thor Polymers Private Limited
Active
36 years 2 months Justin Martins and Raoul Verma are mutual person
Star Industries Private Limited
Active 43 years 1 month Justin Martins and Raoul Verma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Vijaya Bank Creation Date: 15 Apr 2004 | ₹2.89 Cr | Satisfied |
How Many Employees Work at Bombay Kunststoff Pharma Supplies?
Unlock and access historical data on people associated with Bombay Kunststoff Pharma Supplies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bombay Kunststoff Pharma Supplies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bombay Kunststoff Pharma Supplies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
